Seeing Is Believing
with an average price target of $44.18. This is a potential upside of $21.25 (92.67%) from yesterday's end of day stock price of $22.93.
Landos Biopharma's activity chart (see below) currently has 9 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 26.19% with an average time for these price targets to be met of 123.29 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 01-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$20.42
$-2.51 (-10.95%)
$500
1 years 6 months 7 days ago
(01-Apr-2024)
0/2 (0%)
$-1.18 (-5.46%)
Sell
$14
2 years 9 months 2 days ago
(06-Jan-2023)
1/2 (50%)
$2 (16.67%)
713
Hold
$3
2 years 10 months 28 days ago
(11-Nov-2022)
1/3 (33.33%)
$-7.6 (-71.70%)
87
Buy
3 years 1 months 26 days ago
(12-Aug-2022)
0/1 (0%)
$167.4 (102.95%)
Hold
$70
$47.07 (205.28%)
$170
3 years 9 months 5 days ago
(03-Jan-2022)
0/2 (0%)
$17.8 (34.10%)
What is LABP (Landos Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on LABP (Landos Biopharma) with a proven track record?
Which analyst has the current lower performing score on LABP (Landos Biopharma) with a proven track record?
Which analyst has the most public recommendations on LABP (Landos Biopharma)?
Which analyst is the currently most bullish on LABP (Landos Biopharma)?
Which analyst is the currently most reserved on LABP (Landos Biopharma)?